EP Solutions

EP Solutions would like to thank LSI Europe and its attendees for the engaging and productive discussions that followed our CEO Marcin Gołębicki's presentation yesterday. The event provided an excellent platform to showcase our remarkable progress in enhancing the lives of heart failure patients and improving the clinical outcomes of cardiac resynchronisation therapy. The presentation highlighted our company's innovative approaches and recent breakthroughs, demonstrating EP Solutions' commitment to advancing cardiac care. The enthusiastic response from the audience underscored the significance of our work and its potential impact on patient care. We are encouraged by the insightful feedback and valuable connections made during the event. These interactions will undoubtedly fuel our ongoing efforts to revolutionize cardiac resynchronisation therapy and make a meaningful difference in the lives of those affected by heart failure. #heartfailure #lsi2024 #ecgi #noninvasive

Come and join us tomorrow Tuesday 17 September at 10.35 at LSI Europe in Sintra, Portugal, and learn how EP Solutions can improve the health of heart failure patients !

EP Solutions is proud to share that it passed its ISO13485 re-certification without any non-conformities, demonstrating its commitment to quality and operational excellence on its journey to helping heart failure patients indicated for cardiac resynchronisation therapy. Many thanks to the entire team for the excellent work and for putting quality first. #ecgi #heartfailure #crt #medicaldevice #noninvasive

EP Solutions is proud to share that it passed its ISO13485 re-certification without any non-conformities, demonstrating its commitment to quality and operational excellence on its journey to helping heart failure patients indicated for cardiac resynchronisation therapy. Many thanks to the entire team for the excellent work and for putting quality first. #ecgi #heartfailure #crt #medicaldevice #noninvasive

EP Solutions is proud to share that it passed its ISO13485 re-certification without any non-conformities, demonstrating its commitment to quality and operational excellence on its journey to helping heart failure patients indicated for cardiac resynchronisation therapy. Many thanks to the entire team for the excellent work and for putting quality first. #ecgi #heartfailure #crt #medicaldevice #noninvasive

We are thrilled to announce that EP Solutions SA has successfully raised 4 M€ in funding ! This investment will drive our two key initiatives: (1) our multicentre, randomised and controlled study ICONIC-M, currently enrolling patients; and (2) the development of CRiTeria, our second-generation noninvasive planning system for cardiac resynchronisation therapy. We are excited to advance our mission of improving cardiac care through innovative technology. Stay tuned for updates ! #crt #ecgi #noninvasive #medtech #heartfailure

The team at #EP Solutions would like to thank Prof Paul Wang, who founded the annual Stanford Biodesign Digital Health , New Arrhythmia Technologies Retreat more than twenty years ago, and Prof. Niraj Varma, of Cleveland Clinic , for updating the audience on the progress of EP Solutions' project at this year's retreat in Boston last week. EP Solutions is currently collecting clinical evidence to demonstrate that its innovative and noninvasive technology improves the clinical outcome of heart failure patients undergoing cardiac resynchronisation therapy. #EP #AI #CRT #HRS #noninvasive

See you in Boston on Wednesday!

The Stanford Biodesign New Arrhythmia Technologies Retreat will take place in Boston on 15 May 2024. EP Solutions is proud to announce the presentation by Prof. Niraj Varma of Cleveland Clinic, who will update the audience on EP Solutions' clinical programme and product improvements. Marcin Gołębicki of EP Solutions will be in attendance and are looking forward to productive exchanges about improving heart failure patients' response to cardiac resynchronisation therapy. #crt #ecgi #heartfailure #stanfordbiodesign #hrs

See you in Dublin on April 18th, our CEO Marcin Gołębicki will present our breakthrough #heartfailure technology saving patients and lowering cost of healthcare!